0:00
11:00
@ michaelsalzle Patients with diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. The FLOW trial looked at the safety and efficacy of semaglutide in patients with chronic disease and type 2 diabetes.
Otros episodios de "Healthspan"
No te pierdas ningún episodio de “Healthspan”. Síguelo en la aplicación gratuita de GetPodcast.